JP2024523363A5 - - Google Patents

Info

Publication number
JP2024523363A5
JP2024523363A5 JP2023577658A JP2023577658A JP2024523363A5 JP 2024523363 A5 JP2024523363 A5 JP 2024523363A5 JP 2023577658 A JP2023577658 A JP 2023577658A JP 2023577658 A JP2023577658 A JP 2023577658A JP 2024523363 A5 JP2024523363 A5 JP 2024523363A5
Authority
JP
Japan
Prior art keywords
modified oligonucleotide
nucleoside
modified
nucleic acid
nucleosides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023577658A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024523363A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/033936 external-priority patent/WO2022266415A1/en
Publication of JP2024523363A publication Critical patent/JP2024523363A/ja
Publication of JP2024523363A5 publication Critical patent/JP2024523363A5/ja
Pending legal-status Critical Current

Links

JP2023577658A 2021-06-18 2022-06-17 Ifnar1の発現を低減するための化合物及び方法 Pending JP2024523363A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163212476P 2021-06-18 2021-06-18
US63/212,476 2021-06-18
PCT/US2022/033936 WO2022266415A1 (en) 2021-06-18 2022-06-17 Compounds and methods for reducing ifnar1 expression

Publications (2)

Publication Number Publication Date
JP2024523363A JP2024523363A (ja) 2024-06-28
JP2024523363A5 true JP2024523363A5 (cg-RX-API-DMAC7.html) 2025-06-25

Family

ID=84527458

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023577658A Pending JP2024523363A (ja) 2021-06-18 2022-06-17 Ifnar1の発現を低減するための化合物及び方法

Country Status (4)

Country Link
US (1) US20250188476A1 (cg-RX-API-DMAC7.html)
EP (1) EP4355338A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024523363A (cg-RX-API-DMAC7.html)
WO (1) WO2022266415A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11753644B2 (en) 2021-06-18 2023-09-12 Ionis Pharmaceuticals, Inc. Compounds and methods for reducing IFNAR1 expression
TW202442242A (zh) * 2023-04-21 2024-11-01 德商瑟卡爾納製藥有限兩合公司 Nrp1-特異性反義寡核苷酸及其等在預防及/或治療疾病的用途
EP4724582A1 (en) * 2023-06-07 2026-04-15 Massachusetts Institute of Technology Rna-loaded lipid nanoparticles

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0807172A1 (en) * 1995-01-30 1997-11-19 HYBRIDON, Inc. Human immunodeficiency virus transcription inhibitors and methods of their use
AU2001250572A1 (en) * 2000-04-07 2001-10-23 Epigenomics Ag Detection of single nucleotide polymorphisms (snp's) and cytosine-methylations
US20070093437A1 (en) * 2001-05-18 2007-04-26 Sirna Therapeutics, Inc. Rna interference mediated inhibition of xiap gene expression using short interfering nucleic acid (sina)
WO2009028945A2 (en) * 2007-08-30 2009-03-05 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Pathways involved in arteriogenesis and uses thereof
WO2012068630A1 (en) * 2010-11-26 2012-05-31 The University Of Melbourne Methods and compositions comprising antagonists of type 1 interferon-mediated signalling for reducing a neuroinflammatory response in the central nervous system following a stroke
WO2013151664A1 (en) * 2012-04-02 2013-10-10 modeRNA Therapeutics Modified polynucleotides for the production of proteins
KR20160027968A (ko) * 2013-06-07 2016-03-10 라나 테라퓨틱스, 인크. Foxp3 발현을 조절하기 위한 조성물 및 방법
WO2016009430A1 (en) * 2014-07-14 2016-01-21 Yeda Research And Development Co. Ltd Reduction of aging-induced type i interferon signaling at the brain's choroid plexus or within the cns for treatment of disease or injury of the cns
CN104312973B (zh) * 2014-10-09 2017-04-26 北京师范大学 I型干扰素在诱导atx蛋白表达中的应用
CN107429250B (zh) * 2015-04-03 2022-03-01 Ionis制药公司 用于调节tmprss6表达的化合物和方法
EP3419643A4 (en) * 2016-02-24 2020-04-01 Children's Hospital of Eastern Ontario Research Institute Inc. SMC COMBINATION THERAPY FOR TREATING CANCER
US20200190587A1 (en) * 2017-04-28 2020-06-18 Avellino Lab Usa, Inc. Methods for Detecting Alleles Associated with Keratoconus
EP3672579A4 (en) * 2017-10-10 2021-06-23 University of Virginia Patent Foundation COMPOSITIONS AND METHODS OF TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND GEOGRAPHICAL ATROPHY
AU2019218987B2 (en) * 2018-02-12 2025-04-24 Ionis Pharmaceuticals, Inc. Modified compounds and uses thereof
SG11202101946YA (en) * 2018-09-18 2021-04-29 I Mab Biopharma Hangzhou Co Ltd Anti-ifnar1 antibodies for treating autoimmune diseases
WO2020072991A1 (en) * 2018-10-05 2020-04-09 Ionis Pharmaceuticals, Inc. Modified oligomeric compounds and uses thereof
US12281305B2 (en) * 2018-11-21 2025-04-22 Ionis Pharmaceuticals, Inc. Compounds and methods for reducing prion expression
TW202536179A (zh) * 2019-03-29 2025-09-16 美商Ionis製藥公司 用於調節ube3a-ats之化合物及方法
US20220372560A1 (en) * 2019-10-30 2022-11-24 Takeda Pharmaceutical Company Limited Methods for detecting oligonucleotides

Similar Documents

Publication Publication Date Title
JP7554488B2 (ja) 血液脳関門通過型ヘテロ2本鎖核酸
JP2024520205A5 (cg-RX-API-DMAC7.html)
JP2024539596A5 (cg-RX-API-DMAC7.html)
JP2020193199A5 (cg-RX-API-DMAC7.html)
JP2022518929A5 (cg-RX-API-DMAC7.html)
JP2023536472A5 (cg-RX-API-DMAC7.html)
JP2024504377A5 (cg-RX-API-DMAC7.html)
JP2022520986A5 (cg-RX-API-DMAC7.html)
JP2023536994A5 (cg-RX-API-DMAC7.html)
JP2023528755A5 (cg-RX-API-DMAC7.html)
AU2018375807A1 (en) Angelman syndrome antisense treatment
JP2023543215A5 (cg-RX-API-DMAC7.html)
CN119790152A (zh) 使用unc13a基因转录本的调节剂治疗神经系统疾病
JP2023530072A5 (cg-RX-API-DMAC7.html)
JP2024059839A (ja) Smn2を調節するための化合物及び方法
JP2023549563A5 (cg-RX-API-DMAC7.html)
JP2022500079A5 (cg-RX-API-DMAC7.html)
JP2022515140A5 (cg-RX-API-DMAC7.html)
JP2024523363A (ja) Ifnar1の発現を低減するための化合物及び方法
JP7737667B2 (ja) 核酸複合体
JP2021510512A5 (cg-RX-API-DMAC7.html)
JP2023528435A5 (cg-RX-API-DMAC7.html)
JP2023532518A5 (cg-RX-API-DMAC7.html)
WO2022211129A1 (ja) Atn1のアンチセンスオリゴヌクレオチド誘導体
TW202516004A (zh) 調節jak1表現之雙股寡核苷酸